6 Social Security Changes Americans Are Strongly Opposed To
Social Security is now less than a decade away from insolvency. Contrary to what some people believe, this doesn't mean the program will disappear. Even today's youngest workers can expect something in retirement.
Verona Pharma Announces March 2025 Investor Conference Participation - Verona Pharma ( NASDAQ:VRNA )
LONDON and RALEIGH, N.C., Feb. 18, 2025 ( GLOBE NEWSWIRE ) -- Verona Pharma plc VRNA ( "Verona Pharma" or the "Company" ) announces that senior management will present a company overview at the following conferences in March 2025:
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® ( aflibercept )
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical ...
Diamondback Energy, Inc. Announces Midland Basin Acquisition
MIDLAND, Texas, Feb. 18, 2025 ( GLOBE NEWSWIRE ) -- Diamondback Energy, Inc. ( NASDAQ: FANG ) ( "Diamondback" or "the Company" ) today announced that it has entered into a definitive purchase agreement to acquire certain subsidiaries of Double Eagle IV Midco, LLC ( "Double Eagle" ) in exchange ...
Automotive Wheels Aftermarket Industry Size is Projected to Reach USD 18.11 Billion by 2033, Growing at a CAGR of 2.5%: Straits Research
New York, United States, Feb. 18, 2025 ( GLOBE NEWSWIRE ) -- The automotive wheels aftermarket refers to the market segment that involves the sale and installation of replacement or upgraded wheels for vehicles after the original purchase.
Zymeworks Announces Appointment of Oleg Nodelman to Board of Directors
VANCOUVER, British Columbia, Feb. 18, 2025 ( GLOBE NEWSWIRE ) -- Zymeworks Inc. ( Nasdaq: ZYME ) , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, ...
Verona Pharma Announces March 2025 Investor Conference Participation
LONDON and RALEIGH, N.C., Feb. 18, 2025 ( GLOBE NEWSWIRE ) -- Verona Pharma plc ( Nasdaq: VRNA ) ( "Verona Pharma" or the "Company" ) announces that senior management will present a company overview at the following conferences in March ...
Aktsiaselts Infortar Investor Webinar introducing the results of the Q4 2024
Infortar will organize a webinar for investors on 25 February 2025 at 12:00 ( EET ) in Estonian and at 14:00 ( EET ) in English to introduce the fourth quarter 2024 results. The webinar will be attended by the Chairman of the Board of Infortar Ain Hanschmidt, the Managing Director of Infortar ...
Hesai Group to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 10, 2025 - Hesai Gr ( NASDAQ:HSAI )
SHANGHAI, China, Feb. 18, 2025 ( GLOBE NEWSWIRE ) -- Hesai Group ( "Hesai," "Hesai Technology" or the "Company" ) HSAI, the global leader in three-dimensional light detection and ranging ( lidar ) solutions, today announced that it will report its fourth quarter and full year 2024 unaudited ...
Hong Kong playing 'crucial' role in yuan's internationalisation
Already the world's biggest offshore yuan hub, city's role will increase as liquidity and uses expand, officials and experts say.














